BioCrossroads invests in innovative biotech targeting challenging diseases

Press Release Contact: Lori LeRoy BioCrossroads lleroy@biocrossroads.com 317-238-2456     317-514-0095 cell   BioCrossroads invests in innovative biotech targeting challenging diseases Aarden Pharmaceuticals continues to advance cutting-edge discoveries Indianapolis, December 23, 2010 –  BioCrossroads’ Indiana Seed Fund has announced its eleventh investment, committing $250,000 to biotech start-up Aarden Pharmaceuticals.Based in Indianapolis but drawing [...]

BioCrossroads invests in medical device company developing revolutionary absorbable stent

Zorion Medical’s novel biomaterial achieves positive results in initial pre-clinical study Indianapolis, October 20, 2011 – BioCrossroads’ Indiana Seed Fund has announced its twelfth investment, committing $300,000 to medical device start-up Zorion Medical. Zorion is developing a breakthrough device that combines novel biomaterials with known drug and drug delivery technology in [...]

BioCrossroads Awards Indiana Life Sciences Leaders

Press Release Contact: Lori LeRoy BioCrossroads 317-238-2456/317- 514-0095 (cell) lleroy@biocrossroads.com BioCrossroads Awards Indiana Life Sciences Leaders The late Bill Cook receives the Watanabe Life Sciences Champion of the Year Award for countless contributions to Indiana’s communities and to worldwide health; Anne Shane receives inaugural BioCrossroads Catalyst Award for productivity and [...]

November 1, 2012

Eli Lilly Chairman, President and CEO John Lechleiter calls for more industry-academic collaboration

Indiana at the (Bio)Crossroads, speech by John Lechleiter, Chairman, president, and CEO, Eli Lilly and Company at Indiana Life Sciences Summit, Oct. 23, 2012 http://lilly.com/news/speeches/Pages/120701.aspx